The Enhanced Angiogenic Cell Therapy - Acute Myocardial Infarction Trial
The Enhanced Angiogenic Cell Therapy - Acute Myocardial Infarction Trial
Active, not recruiting · NCT00936819 · Registry updated 2025-08-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Enhanced Angiogenic Cell Therapy - Acute Myocardial Infarction Trial | Infarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, anterolateral myocardial infarction, cardiovascular disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorder | Active, not recruiting | Phase 2 | 2025-08-15 | NCT00936819 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Canadian Institutes of Health Research (CIHR) | 339 |
| Ottawa Hospital Research Institute | 121 |
| Stem Cell Network | 8 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| L'institut de cardiologie de Montreal | Montreal | Canada | 1 |
| St. Michael's Hospital | Toronto | Canada | 62 |
| University of Ottawa Heart Institute | Ottawa | Canada | 61 |